Tools
Search
Import
Library
Explore
Videos
Channels
Figures
Atmrix
About
Tools
Search
Import
Library
Explore
Videos
Channels
Figures
Atmrix
About
Go Back
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
OpenEvidence is trained on peer-reviewed medical literature, serving as an AI co-pilot that assists doctors in making better decisions at the point of care, which is undeniably beneficial for humanity.
Video
SC
The AI Product Going Viral With Doctors: OpenEvidence, with CEO Daniel Nadler
@ Sequoia Capital
03/04/25
Related Takeaways
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
OpenEvidence's approach to training AI models is distinct; it does not connect to the public internet, ensuring that the information provided is based solely on vetted medical research. Additionally, OpenEvidence has formed a strategic partnership with the New England Journal of Medicine, which is unique as they typically do not allow AI companies to train on their research.
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
OpenEvidence addresses the challenge of finding specific medical information by providing a streamlined way for doctors to access relevant studies and data, improving patient care outcomes.
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
The use of OpenEvidence has already saved lives by helping doctors make better clinical decisions based on accurate medical information.
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
OpenEvidence allows doctors to drill down to the underlying sources of information, fostering a symbiotic relationship with medical publishers by driving traffic to their journals.
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
We built OpenEvidence by assembling a team of PhD-level scientists from top institutions, focusing on creating specialized AI models trained on peer-reviewed medical literature.
ZZ
Zachary Ziegler
05/12/25
@ Sequoia Capital
Open Evidence has the opportunity to aggregate medical knowledge from millions of physicians worldwide, encoding and improving care by leveraging distributed clinical wisdom.
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
OpenEvidence's platform is freely available to all physicians, leading to widespread organic adoption and strategic partnerships with publishers like the New England Journal of Medicine.
ZZ
Zachary Ziegler
05/12/25
@ Sequoia Capital
Open Evidence is a medical search platform that has grown to support over 25% of US practicing physicians as monthly active users, with many using it daily for critical information.
DN
Daniel Nadler
03/04/25
@ Sequoia Capital
OpenEvidence serves not only elite hospitals but also community practices, providing essential medical knowledge to doctors in underserved areas who cannot afford expensive subscriptions.